RxDoctor Payments Data

Maria Borelli, MD

Family Medicine · Columbus, GANPI 1689868960

Payments from drug & device makers

$3,377in general payments, 2019–2025

Across 230 payments — averaging $14.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$614
  • Novartis$285
  • Astellas Pharma US Inc$130
  • Boehringer Ingelheim$122
  • GSK$121
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$3,377100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,377 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$104,984
Medicare patients
192
Services billed
2,703

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$86,575
EliquisApixaban55$61,695
FarxigaDapagliflozin Propanediol44$48,045
JardianceEmpagliflozin54$47,678
LinzessLinaclotide47$44,064
MounjaroTirzepatide23$32,872
MyrbetriqMirabegron41$28,916
XareltoRivaroxaban24$24,578
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$23,494
RybelsusSemaglutide12$22,451
JanuviaSitagliptin Phosphate14$18,534
Tresiba Flextouch U-200Insulin Degludec26$16,000
TradjentaLinagliptin19$12,719
TrintellixVortioxetine Hydrobromide11$5,255
Breo ElliptaFluticasone/Vilanterol13$5,201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,038$109,02668 claims
PfizerEliquis$61$61,69555 claims
Boehringer IngelheimJardiance, Tradjenta$122$60,39673 claims
AstraZenecaFarxiga$25$48,04544 claims
AbbVieLinzess, Synthroid$614$47,518113 claims
Lilly USA, LLCMounjaro$118$32,87223 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$121$31,76046 claims
Astellas Pharma US IncMyrbetriq$130$28,91641 claims
Johnson & JohnsonXarelto$26$24,57824 claims
MerckJanuvia$53$18,53414 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$19$5,25511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Columbus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →